Drug maker Krka posts EUR 153m net profit for 2017, up 41% Y/Y
Novo Mesto, 22 March - Pharma company Krka saw group net profit increase 41% in 2017 to EUR 152.6m, on sales that rose 8% to EUR 1.27bn, a new record for the company, show unaudited results released on Thursday.
Novo Mesto
Jože Colarič, the CEO of pharmaceutical company Krka, speaks to the press about results for 2017 and plans for this year
Photo: Rasto Božič/STA
Novo Mesto
Jože Colarič, the CEO of pharmaceutical company Krka, speaks to the press about results for 2017 and plans for this year
Photo: Rasto Božič/STA
Novo Mesto
Jože Colarič, the CEO of pharmaceutical company Krka, speaks to the press about results for 2017 and plans for this year
Photo: Rasto Božič/STA
Novo mesto
Pharma company Krka logo
Photo: Rasto Božič/STA
The rest of this news item is available to subscribers.
The news item consists of 1.167 characters (without spaces) or 244 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.